Basic Information
Origimm is an Austrian biotechnology company with leading expertise in the discovery of vaccine antigens and drug targets to prevent and treat diseases and infections associated with skin-colonizing microorganisms.
Origimm Biotechnology GmbH
Vienna,Vienna,Austria
15~50 people
January 01, 2012
dpo@origimm.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios